O’Melveny Represents CapsoVision in Nasdaq IPO
July 7, 2025
FOR IMMEDIATE RELEASE
SILICON VALLEY—July 7, 2025— O’Melveny represented CapsoVision, Inc. (Nasdaq: CV) on its initial public offering and listing on the Nasdaq. The offering size was approximately US$27.5 million.
CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence technologies to transform the detection and diagnosis of gastrointestinal diseases.
The Benchmark Company, LLC and Roth Capital Partners, LLC are acting as joint book-running managers for the offering.
The team was led by partner Portia Ku, with support from partner Kurt Berney. The core team members additionally included counsel Jane Wu, associate Sharon Yang, senior legal consultant Aaron Xin, and legal consultants Nick Mu and Yingqi Gu.
About O’Melveny
It’s more than what you do: it’s how you do it. Across sectors and borders, in board rooms and courtrooms, we measure our success by yours. And in our interactions, we commit to making your O’Melveny experience as satisfying as the outcomes we help you achieve. Our greatest accomplishment is ensuring that you never have to choose between premier lawyering and exceptional service. So, tell us. What do you want to achieve? Visit us at www.omm.com; learn more in our firm at-a-glance; and find us on LinkedIn, Facebook, Instagram, and YouTube.
Contact:
Brandon Jacobsen
O’Melveny & Myers LLP
+1 213 430 8024
bjacobsen@omm.com
Chris Schob
O’Melveny & Myers LLP
+86 21 2307 7000
cschob@omm.com
# # #